Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: A phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick, Peter J. Goadsby, Egilius L.H. Spierings, Joel C. Scherer, Steven P. Sweeney, David S. Grayzel
Dive into the research topics of 'Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: A phase 2, randomised, double-blind, placebo-controlled study'. Together they form a unique fingerprint.